Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (396)	2/24/1998 7:19:00 AM
From: Bharat H. Barai	Read Replies (3) \| Respond to of 442

Dear Mike, What ever I write on this thread, I am writing as a Hematologist for fun and hobby. You can assume that whatever I am writing, I am writing with no bias or prejudice and for sharing information. I WILL NEVER DO ANYTHING THAT WILL BRING SHAME TO MY HONOR, HONESTY,INTEGRITY AND REPUTATION. I believe once scientific information is presented in simple format, most individuals are smart enough to make their own decisions, based on their own philosophy, needs, wants and resources. I invested in Somatogen because I believe that it has an extra ordinary unique product, badly needed by Humanity and medical profession. The scientific efforts and achievement of producing 500 genetically engineered recombinant Hemoglobin molecules is mind boggling. Because of number of mishaps in trials and business arrangements, this Diamond has been in dumpster. The 2nd generation recombinant Hemoglobin molecule should turn around this situation. BHARAT H. BARAI MD